J Smith-Palmer

Summary

Affiliation: IMS Health

Publications

  1. ncbi Anti-CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis
    J Smith-Palmer
    IMS Health, Allschwil, Switzerland
    Diabet Med 27:189-96. 2010

Detail Information

Publications1

  1. ncbi Anti-CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis
    J Smith-Palmer
    IMS Health, Allschwil, Switzerland
    Diabet Med 27:189-96. 2010
    ..In the absence of suitable empirical evidence, the objective of this study was to estimate the potential long-term clinical outcomes associated with treatment via a hypothetical modelling analysis...